Skip to content

ACS MEDICAL

Active Private limited companyfounded 2020active for 6 yearsAvenue du Bois Impérial Rognac 51, 4121 NeupréKBO/BCE: BE 0754.927.937

Lifetime

5 annual accounts with figures on one time axis
peak of €124,275 in 2025
€124,275▲ 15.7%
peak of €86,933 in 2025
€86,933▲ 16.1%
peak of €226,777 in 2024
€157,808▼ 30.4%
€106,457▲ 258%
Board2 names since 2020
1 director
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Gross margin from €107,441 to €124,275Registered office moved from Blegny to Neupré 29-08Dividend €155,900Equity from €226,777 to €157,808Debts from €29,768 to €106,457Cash from €123,740 to €200,688

Key points

from the 2025 annual accounts

Equity

€157,808 ▼ 30.4%
226,7772024+86,933Profit-155,900Dividend-2Other157,8082025

ACS MEDICAL paid out €155,900 in dividends. That is 179% of the 2025 profit.

Turnover

≈ €230,000 estimated

The micro format states no turnover.

Liquidity

2.30 was 14.34 in 2024

Short-term debts rose from €14,412 to €98,614.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as ACS MEDICAL has now. Each dot stands for 68 companies, two years later.

94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for ACS MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • all the sharesdeed of 27-04-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0754927937
Registered office moved from Blegny to Neupré The registered office moved from Route du Pays de Liège 52, 4671 Blégny to Avenue du Bois Impérial Rognac, 51 à 4121 Neupré · General meeting of 19-04-2025 · Gazette deed
appointed as director holds all the shares · General meeting of 03-01-2023 · Gazette deed
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 29-09-2020 · Gazette deed
All 14 events

Comparable companies

same main activity, similar in size and age
Company
ACS MEDICAL Neupré €264,265 €124,275 59.7% -
Docteur Caroline DAL PONT Anthisnes €228,531 €118,788 56.7% -
DEP AVI Villers-la-Ville €257,609 €122,981 45.5% -
AmbEryn Bertem €266,500 €122,554 84.1% 0
Dr Borremans Etterbeek €240,229 €135,997 0.6% -
Lebrun Anesthésie Namur €290,139 €137,215 1.7% -
KOTANIDIS Marche-en-Famenne €302,880 €119,030 97.5% -

These companies have the same main activity as ACS MEDICAL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €229,000 and €303,000, founded between 2019 and 2021.

Official details

Source: KBO
Status
Active since 25-09-2020Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.308.034.2324121 Neupré, since 25-09-2020
Financial year end
31 December
Peppol
Reachable since 29-10-2025
Company details

Annual accounts 2025

€264,265▲ 3.0%
Filing
Filed on 26-06-2026, 35 days before the end of the filing period
Financials

Insights on ACS MEDICAL

ACS MEDICAL files the micro format. That format states no turnover. The gross margin rose from €88,999 in 2021 to €124,275 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ACS MEDICAL

What is the company number of ACS MEDICAL?
The company number of ACS MEDICAL is 0754.927.937. The VAT number is the same number with BE in front: BE 0754.927.937.
Where is ACS MEDICAL based?
The registered office is at Avenue du Bois Impérial Rognac 51, 4121 Neupré.Company details
What does ACS MEDICAL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ACS MEDICAL?
ACS MEDICAL is a private limited company (BV).
When was ACS MEDICAL founded?
ACS MEDICAL was founded on 25-09-2020.
Is ACS MEDICAL still active?
Yes, ACS MEDICAL is an active enterprise in the KBO register.
What is the turnover of ACS MEDICAL?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €124,275 and 40 comparable companies (NACE 86220). It probably lies between €200,000 and €310,000.Financials
Is ACS MEDICAL profitable?
In financial year 2025, ACS MEDICAL made a profit of €86,933.
Where can I find the annual accounts of ACS MEDICAL?
ACS MEDICAL filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ACS MEDICAL due?
ACS MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.